tradingkey.logo
tradingkey.logo
Search

Klotho Neurosciences Ord Shs

GRML
Add to Watchlist
0.391USD
+0.045+13.13%
Close 04/15, 16:00ETQuotes delayed by 15 min
10.60MMarket Cap
LossP/E TTM
You can access the annual and quarterly cash flow statements of Klotho Neurosciences Ord Shs to evaluate its financial soundness and stability.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q4
FY2025Q3
Operating cash flows (indirect method)
Cash flow from continuing operating activities
---1.28M
---1.09M
Net income from continuing operations
---1.33M
---2.90M
Other non-cash items
--1.69M
----
Change in working capital
---57.12K
--26.60K
-Change in receivables
---10.22K
--10.22K
-Change in prepaid expenses
---30.77K
---13.55K
Cash from non-recurring investing activities
Cash from operating activities
---1.28M
---1.09M
Investing cash flow
Cash from non-current investing activities
Financing cash flow
Cash flow from continuous financing activities
--1.11M
--5.30K
Net cash flow from debt Issuance/repayment
--0.00
--0.00
Net cash flow from common stock issuance/repurchase
--1.11M
--0.00
Net cash flow from preferred stock issuance/repurchase
--0.00
--0.00
Proceeds from stock option exercised by employees
--0.00
--500.00K
Net cash flow from other financing activities
--0.00
---494.70K
Net cash from non-recurrent financing activities
Net cash from financing activities
--1.11M
--5.30K
Net cash flow
Beginning cash balance
--7.35M
--8.43M
Current period cash flow changes
---171.42K
---1.08M
Ending cash balance
--7.18M
--7.35M
Currency unit
USD
USD
Audit opinions
--
--

FAQs

What is the cash flow statement?

This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.
KeyAI